Targeted cancer therapies have revolutionized cancer care by offering more effective treatments with fewer side effects compared to conventional chemotherapy. These therapies are designed to specifically target cancer cells, leaving healthy cells unharmed, and work by interfering with specific molecules and proteins that are involved in the growth and spread of cancer. Unlike chemotherapy, which attacks both cancerous and healthy cells, targeted therapies have a more targeted approach, reducing the damage to healthy tissues and organs. Additionally, these therapies are tailored to the genetic makeup of the tumor, providing personalized treatment options.
Targeted Cancer Therapies have been approved for the treatment of various types of cancer, including breast, lung, and colorectal cancer, and are currently being developed for the treatment of other types of cancer. As the field of targeted cancer therapies continues to evolve, we can expect to see more personalized and effective treatments that are tailored to the specific needs of each patient, ultimately leading to improved outcomes and a better quality of life for cancer patients.The main benefit of targeted cancer therapies is that they attack only cancer cells and spare healthy cells. This is different from chemotherapy, which attacks all fast-dividing cells in the body. When cancer cells grow, they do it quickly and in ways that aren't natural. This happens as the cancer cells have changed their genes. To treat these changes, targeted cancer therapies interfere with the proteins or genetic mutations that help cancer cells grow and spread.
They also mark cancer cells so that the immune system can find and destroy them. These treatments can be given as pills, by an IV drip or as an injection under the skin. Some types of targeted therapies block or turn off signals that cause cancer cells to grow and divide, and others tell the cancer cells to self-destruct. Others go after substances that trigger blood vessel growth, so that cancer can't get oxygen and nutrients it needs to grow. Another way that targeted therapies work is by starving cancer of the hormones it needs to grow. Hormone-sensitive breast and prostate cancers respond well to these medicines, which cut off the hormones that stimulate the tumor's growth.
Read More:
Her2 positive breast cancer was considered incurable 20 years ago.
With the advent of a plethora of targeted therapies against the Her2 gene – we are curing many women with Breast cancer.
In the years to come, this group of patients will have the best prognosis.
They will also have chemotherapy-free treatments and receive only anti Her2 antibodies, be it in early or late-stage disease.
The treatment of Her2 positive Breast Cancer Treatment in Pune has truly been a breakthrough in cancer medicine.Progress in Cancer Treatment and Cancer Treatment in Pune
Targeted cancer therapy uses pharmacological agents that inhibit growth, increase cell death, and restrict the spread of cancer; however, it targets specific type of proteins that helps in tumorigenesis.
Moreover, new technological development and recent medical advancements have made it possible to analyze the type of cancer and provide customized treatments to the patient.Request Brochure – https://www.transparencymarketresearch.com/sample/sample.php?flag=B_id=32447 The global targeted cancer drug market can be segmented based on drug type, distribution channel, and region.
Monoclonal antibodies include drugs such as Bevacizumab (humanized monoclonal antibody with a circulatory system target (VEGF-A), Cetuximab (chimeric monoclonal antibody with a tumor target (EGFR)) and Ipilimumab (fully human antibody with an immune system target (CTLA-4)).
In terms of the distribution channel, market is divided into drug stores, retail pharmacies, hospital pharmacy, and online sales.Request TOC of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=T_id=32447 Rise in the number of newly diagnosed patients, rigorous research & development activities, adverse side effects of conventional chemotherapy, and a rise in public awareness toward chronic illness are major factor driving the growth of targeted cancer drug market.
However, high cost of the treatment, little to no reimbursement in developing economies, unavailability of the treatment in Asian countries such as India, and a shortage of skilled professionals are some factors restraining the growth of the targeted cancer drugs market.
Opportunities available in order to make the treatment more convenient for the patients and to dominate targeted cancer drugs market includes the introduction of robotics and automation for surgeries, more emphasis towards painless treatment and increasing population of smokers and drug addicts.
